Currently, the European Society of Cardiology consider that ACE inhibitors are safe and support their continued usage according to national guidelines, and note the lack of data supporting harmful effect.10 In the UK, NICE also cite the poor quality of available studies and were unable to conclude whether ACE inhibitors increase the risk of infection or severe outcomes with SARS-CoV-2 infection.11 This evidence concerns the gene ACE and infection.